Urinary Biomarker Study With Sulindac and Difluoromethylornithine
Stopped Funding and staffing
Conditions
- Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms
Interventions
- DRUG: difluoromethylornithine
- DRUG: Sulindac
Sponsor
Cancer Prevention Pharmaceuticals, Inc.
Collaborators